Vaccines

New model captures glycan molecules whose motions shield much of the spike from immune defenses

This next-generation automated platform aims to solve the challenges commonly associated with batch production of lipid nanoparticles and liposomes for drug and vaccine development

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

Preliminary results show that the vaccine has performed well in animal studies, and clinical testing in humans will start within a few months

Worrisome new coronavirus variants can evade antibodies that neutralize original virus, recent lab research shows

A research team suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible

These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines

Breakthroughs in vaccine development achieved in just 10 months show value of working together

Panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples